Cooperative Agreement UG3CA286852
Award Date
9/19/24
Completion Date
8/31/26
Dollars Obligated
$663K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Cooperative Agreement
Place of Performance
Boston, MA 02114, USA
Similar Awards
This Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program) provides $257,413 to the Dartmouth-Hitchcock Clinic to develop and evaluate an interactive visual aid (VIS) that can facilitate patient-clinician communication and shared understanding around decisions to stop cancer treatment for patients with advanced cancer. The key objectives are to: 1) Assess patient-caregiver-clinician shared understanding following serious illness conversations in...
The University of Alabama at Birmingham received a $661,845 federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to study structural racism's impact on the quality of end-of-life care for children with cancer. The 5-year project aims to examine how access to care, patient/family interactions with the healthcare system, and stress influence variations in quality of end-of-life care, develop a predictive model to identify high-risk...
This $185,693 Project Grant, awarded by the National Cancer Institute (CFDA 93.398 Cancer Research Manpower program), supports a digital health parent coaching intervention to improve neurodevelopmental outcomes for young childhood cancer survivors in underserved communities. The award, effective March 1, 2025 through February 28, 2030, was granted to the Research Institute at Nationwide Children's Hospital, a non-profit research organization. The project aims to develop and evaluate a digital...
The National Cancer Institute (NCI) awarded a $1,338,648 project grant under CFDA Program 93.393, Cancer Cause and Prevention Research, to the University of Pittsburgh. The grant will fund a hybrid effectiveness-implementation trial of the CARES intervention, which aims to improve health-related quality of life for cancer patients experiencing depression, pain, and fatigue. The study will evaluate the effectiveness of CARES in a real-world setting, conduct an implementation evaluation, and...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $227,941 to The Washington University to develop and pilot an electronic health record (EHR)-based communication tool, titled the "Cancer Care Companion", that aims to improve information exchange and self-management for parents of children with cancer. The award period runs from April 12, 2025 to March 31, 2027. The key objectives are to: 1) Co-develop the Cancer...
This Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) provides $637,596.00 to develop and test an intervention to reduce cancer information avoidance and increase colorectal cancer screening. The intervention is a video-based strategy designed to increase self-efficacy and positive affect, thereby reducing defensive avoidance of colorectal cancer information. The project involves a randomized controlled trial (RCT) to evaluate the...
The National Cancer Institute (NCI) awarded a $578,467 Project Grant (CFDA 93.395 - Cancer Treatment Research) to Duke University to conduct a randomized controlled trial evaluating the efficacy of a telehealth-delivered psychosocial intervention called ENGAGE. The goal of the ENGAGE intervention is to decrease symptom interference (e.g., pain, fatigue, distress) and improve quality of life for patients with advanced cancer receiving care in medically underserved areas. The 5-year project will...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $858,166 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct a randomized trial of a targeted palliative care intervention for patients with metastatic breast cancer. The study aims to improve documentation of end-of-life care preferences, delivery of end-of-life care, and participant-reported outcomes for this patient population....
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $398,207 to The Washington University in St. Louis to develop and test a multilevel intervention to improve interdisciplinary communication quality in low-resource pediatric oncology hospitals. The project aims to: 1) evaluate the relationship between communication quality and structure around patient deterioration, 2) identify strategies to improve communication...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) seeks to understand how different forms of integration among oncology care organizations impact the quality and equity of cancer care delivery. The $2,282,687 award to Harvard Medical School, with several sub-awards to partner institutions like Dartmouth-Hitchcock Clinic, Stanford University, and Vanderbilt University Medical Center, will fund a comprehensive research...